VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q90439912 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233201.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q90439912‏
024 ‎‡a 0000-0002-9918-8714‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q90439912‏
100 0 ‎‡a Jose Carlos Alves-Filho‏ ‎‡c researcher (ORCID 0000-0002-9918-8714)‏ ‎‡9 en‏
400 0 ‎‡a Jose Carlos Alves-Filho‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's 15d-PGJ-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice‏
670 ‎‡a Author's 5-lipoxygenase deficiency reduces acetaminophen-induced hepatotoxicity and lethality‏
670 ‎‡a Author's 9The PI3Kγ/AKT signaling pathway mediates peripheral antinociceptive action of dipyrone‏
670 ‎‡a Author's Apocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state.‏
670 ‎‡a Author's Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.‏
670 ‎‡a Author's Budlein A, a Sesquiterpene Lactone From, Alleviates Pain and Inflammation in a Model of Acute Gout Arthritis in Mice‏
670 ‎‡a Author's Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.‏
670 ‎‡a Author's CCR2-deficient mice are protected to sepsis by the disruption of the inflammatory monocytes emigration from the bone marrow‏
670 ‎‡a Author's CCR2 Expression in Neutrophils Plays a Critical Role in Their Migration Into the Joints in Rheumatoid Arthritis.‏
670 ‎‡a Author's CCR4-dependent reduction in the number and suppressor function of CD4Foxp3 cells augments IFN-γ-mediated pulmonary inflammation and aggravates tuberculosis pathogenesis‏
670 ‎‡a Author's CCR5-Positive Inflammatory Monocytes are Crucial for Control of Sepsis‏
670 ‎‡a Author's -Chalcone Attenuates Pain and Inflammation in Experimental Acute Gout Arthritis in Mice‏
670 ‎‡a Author's Cinnamoyloxy-mammeisin Isolated from Geopropolis Attenuates Inflammatory Process by Inhibiting Cytokine Production: Involvement of MAPK, AP-1, and NF-κB.‏
670 ‎‡a Author's Contribution of spinal cord glial cells to L. amazonensis experimental infection-induced pain in BALB/c mice‏
670 ‎‡a Author's Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-κB activation‏
670 ‎‡a Author's DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain‏
670 ‎‡a Author's Differential regulation of oxidative stress and cytokine production by endothelin ETA and ETB receptors in superoxide anion-induced inflammation and pain in mice‏
670 ‎‡a Author's Diosmin reduces chronic constriction injury-induced neuropathic pain in mice.‏
670 ‎‡a Author's DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor‏
670 ‎‡a Author's Frontline Science: Blood-circulating leukocytes fail to infiltrate the spinal cord parenchyma after spared nerve injury‏
670 ‎‡a Author's Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway‏
670 ‎‡a Author's Hesperidin Methylchalcone Suppresses Experimental Gout Arthritis in Mice by Inhibiting NF-κB Activation‏
670 ‎‡a Author's Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: role of ATP-sensitive potassium channels‏
670 ‎‡a Author's IL-1α promotes liver inflammation and necrosis during blood-stage Plasmodium chabaudi malaria‏
670 ‎‡a Author's IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10‏
670 ‎‡a Author's IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis‏
670 ‎‡a Author's IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy‏
670 ‎‡a Author's Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients‏
670 ‎‡a Author's Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis‏
670 ‎‡a Author's Interleukin-10 limits intense acute swimming-induced muscle mechanical hyperalgesia in mice.‏
670 ‎‡a Author's Interleukin-33 Receptor‏
670 ‎‡a Author's Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis.‏
670 ‎‡a Author's Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis‏
670 ‎‡a Author's Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4/MyD88-dependent cytokine cascade in the mice paw‏
670 ‎‡a Author's Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis‏
670 ‎‡a Author's Mechanisms underlying the hyperalgesic responses triggered by joint activation of TLR4.‏
670 ‎‡a Author's Medial plantar nerve ligation as a novel model of neuropathic pain in mice: pharmacological and molecular characterization‏
670 ‎‡a Author's MEK5/ERK5 signaling mediates IL-4-induced M2 macrophage differentiation through regulation of c-Myc expression‏
670 ‎‡a Author's Molecular basis of carrageenan-induced cytokines production in macrophages‏
670 ‎‡a Author's Naringenin mitigates titanium dioxide (TiO)-induced chronic arthritis in mice: role of oxidative stress, cytokines, and NFκB‏
670 ‎‡a Author's Naringenin mitigates titanium dioxide (TiO2)-induced chronic arthritis in mice: role of oxidative stress, cytokines, and NFκB‏
670 ‎‡a Author's Neuroimmune-Glia Interactions in the Sensory Ganglia Account for the Development of Acute Herpetic Neuralgia‏
670 ‎‡a Author's Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis‏
670 ‎‡a Author's Neutrophil extracellular traps mediate joint hyperalgesia induced by immune inflammation‏
670 ‎‡a Author's Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway‏
670 ‎‡a Author's NLRP12 controls arthritis severity by acting as a checkpoint inhibitor of Th17 cell differentiation‏
670 ‎‡a Author's Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner‏
670 ‎‡a Author's Pericytes modulate myelination in the central nervous system‏
670 ‎‡a Author's PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation‏
670 ‎‡a Author's Probucol attenuates lipopolysaccharide-induced leukocyte recruitment and inflammatory hyperalgesia: effect on NF-кB activation and cytokine production‏
670 ‎‡a Author's Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects‏
670 ‎‡a Author's Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-κB and oxidative stress‏
670 ‎‡a Author's Regulation of type 17 helper T-cell function by nitric oxide during inflammation‏
670 ‎‡a Author's Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury‏
670 ‎‡a Author's Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation‏
670 ‎‡a Author's S100A9 plays a pivotal role in a mouse model of herpetic neuralgia via TLR4/TNF pathway‏
670 ‎‡a Author's SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology‏
670 ‎‡a Author's SARS-CoV-2 triggered neutrophil extracellular traps (NETs) mediate COVID-19 pathology‏
670 ‎‡a Author's Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain‏
670 ‎‡a Author's STING regulates metabolic reprogramming in macrophages via HIF-1α during Brucella infection‏
670 ‎‡a Author's Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes‏
670 ‎‡a Author's Superoxide anion-induced pain and inflammation depends on TNFα/TNFR1 signaling in mice‏
670 ‎‡a Author's Targeting IL-33/ST2 signaling: regulation of immune function and analgesia‏
670 ‎‡a Author's Targeting interleukin-1β reduces intense acute swimming-induced muscle mechanical hyperalgesia in mice.‏
670 ‎‡a Author's Targeting nitric oxide as a key modulator of sepsis, arthritis and pain‏
670 ‎‡a Author's TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis.‏
670 ‎‡a Author's TGFβ1 signaling sustains aryl hydrocarbon receptor‏
670 ‎‡a Author's TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of T17 cells by an AHR-independent mechanism‏
670 ‎‡a Author's The Atypical Chemokine Receptor ACKR2 is Protective Against Sepsis.‏
670 ‎‡a Author's The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β‏
670 ‎‡a Author's The citrus flavonone naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κB activation.‏
670 ‎‡a Author's The nitroxyl donor, Angeli's salt, reduces chronic constriction injury-induced neuropathic pain‏
670 ‎‡a Author's The NOD2 signaling in peripheral macrophages contributes to neuropathic pain development‏
670 ‎‡a Author's Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome.‏
670 ‎‡a Author's Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB.‏
670 ‎‡a Author's α1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice‏
909 ‎‡a (orcid) 0000000299188714‏ ‎‡9 1‏
919 ‎‡a sarscov2triggeredneutrophilextracellulartrapsmediatecovid19pathology‏ ‎‡A SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology‏ ‎‡9 1‏
919 ‎‡a stingregulatesmetabolicreprogramminginmacrophagesviahif1αduringbrucellainfection‏ ‎‡A STING regulates metabolic reprogramming in macrophages via HIF-1α during Brucella infection‏ ‎‡9 1‏
919 ‎‡a s100a9playsapivotalroleinamousemodelofherpeticneuralgiaviatlr4tnfpathway‏ ‎‡A S100A9 plays a pivotal role in a mouse model of herpetic neuralgia via TLR4/TNF pathway‏ ‎‡9 1‏
919 ‎‡a succinatereceptordeficiencyattenuatesarthritisbyreducingdendriticcelltrafficandexpansionofth17cellsinthelymphnodes‏ ‎‡A Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes‏ ‎‡9 1‏
919 ‎‡a repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation‏ ‎‡A Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation‏ ‎‡9 1‏
919 ‎‡a superoxideanioninducedpainandinflammationdependsontnfαtnfr1signalinginmice‏ ‎‡A Superoxide anion-induced pain and inflammation depends on TNFα/TNFR1 signaling in mice‏ ‎‡9 1‏
919 ‎‡a targetingil33st2signalingregulationofimmunefunctionandanalgesia‏ ‎‡A Targeting IL-33/ST2 signaling: regulation of immune function and analgesia‏ ‎‡9 1‏
919 ‎‡a targetinginterleukin1βreducesintenseacuteswimminginducedmusclemechanicalhyperalgesiainmice‏ ‎‡A Targeting interleukin-1β reduces intense acute swimming-induced muscle mechanical hyperalgesia in mice.‏ ‎‡9 1‏
919 ‎‡a regulatorytcellscounteractneuropathicpainthroughinhibitionoftheth1responseatthesiteofperipheralnerveinjury‏ ‎‡A Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury‏ ‎‡9 1‏
919 ‎‡a regulationoftype17helpertcellfunctionbynitricoxideduringinflammation‏ ‎‡A Regulation of type 17 helper T-cell function by nitric oxide during inflammation‏ ‎‡9 1‏
919 ‎‡a pyrrolidinedithiocarbamateinhibitssuperoxideanioninducedpainandinflammationinthepawskinandspinalcordbytargetingnfκbandoxidativestress‏ ‎‡A Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-κB and oxidative stress‏ ‎‡9 1‏
919 ‎‡a probucolattenuatesovertpainlikebehaviorandcarrageenaninducedinflammatoryhyperalgesiaandleukocyterecruitmentbyinhibitingnfкbactivationandcytokineproductionwithoutantioxidanteffects‏ ‎‡A Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects‏ ‎‡9 1‏
919 ‎‡a probucolattenuateslipopolysaccharideinducedleukocyterecruitmentandinflammatoryhyperalgesiaeffectonnfкbactivationandcytokineproduction‏ ‎‡A Probucol attenuates lipopolysaccharide-induced leukocyte recruitment and inflammatory hyperalgesia: effect on NF-кB activation and cytokine production‏ ‎‡9 1‏
919 ‎‡a pkm2promotesth17celldifferentiationandautoimmuneinflammationbyfinetuningstat3activation‏ ‎‡A PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation‏ ‎‡9 1‏
919 ‎‡a pericytesmodulatemyelinationinthecentralnervoussystem‏ ‎‡A Pericytes modulate myelination in the central nervous system‏ ‎‡9 1‏
919 ‎‡a paclitaxelreducestumorgrowthbyreprogrammingtumorassociatedmacrophagestoanm1profileinatlr4dependentmanner‏ ‎‡A Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner‏ ‎‡9 1‏
919 ‎‡a nlrp12controlsarthritisseveritybyactingasacheckpointinhibitorofth17celldifferentiation‏ ‎‡A NLRP12 controls arthritis severity by acting as a checkpoint inhibitor of Th17 cell differentiation‏ ‎‡9 1‏
919 ‎‡a nitroxylinhibitsovertpainlikebehaviorinmiceroleofcgmppkgatpsensitivepotassiumchannelsignalingpathway‏ ‎‡A Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway‏ ‎‡9 1‏
919 ‎‡a neutrophilextracellulartrapsmediatejointhyperalgesiainducedbyimmuneinflammation‏ ‎‡A Neutrophil extracellular traps mediate joint hyperalgesia induced by immune inflammation‏ ‎‡9 1‏
919 ‎‡a neutrophilextracellulartrapsinduceorgandamageduringexperimentalandclinicalsepsis‏ ‎‡A Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis‏ ‎‡9 1‏
919 ‎‡a neuroimmunegliainteractionsinthesensorygangliaaccountforthedevelopmentofacuteherpeticneuralgia‏ ‎‡A Neuroimmune-Glia Interactions in the Sensory Ganglia Account for the Development of Acute Herpetic Neuralgia‏ ‎‡9 1‏
919 ‎‡a naringeninmitigatestitaniumdioxidetio2inducedchronicarthritisinmiceroleofoxidativestresscytokinesandnfκb‏ ‎‡A Naringenin mitigates titanium dioxide (TiO2)-induced chronic arthritis in mice: role of oxidative stress, cytokines, and NFκB‏ ‎‡9 1‏
919 ‎‡a naringeninmitigatestitaniumdioxidetioinducedchronicarthritisinmiceroleofoxidativestresscytokinesandnfκb‏ ‎‡A Naringenin mitigates titanium dioxide (TiO)-induced chronic arthritis in mice: role of oxidative stress, cytokines, and NFκB‏ ‎‡9 1‏
919 ‎‡a molecularbasisofcarrageenaninducedcytokinesproductioninmacrophages‏ ‎‡A Molecular basis of carrageenan-induced cytokines production in macrophages‏ ‎‡9 1‏
919 ‎‡a mek5erk5signalingmediatesil4inducedm2macrophagedifferentiationthroughregulationof100mycexpression‏ ‎‡A MEK5/ERK5 signaling mediates IL-4-induced M2 macrophage differentiation through regulation of c-Myc expression‏ ‎‡9 1‏
919 ‎‡a medialplantarnerveligationasanovelmodelofneuropathicpaininmicepharmacologicalandmolecularcharacterization‏ ‎‡A Medial plantar nerve ligation as a novel model of neuropathic pain in mice: pharmacological and molecular characterization‏ ‎‡9 1‏
919 ‎‡a mechanismsunderlyingthehyperalgesicresponsestriggeredbyjointactivationoftlr4‏ ‎‡A Mechanisms underlying the hyperalgesic responses triggered by joint activation of TLR4.‏ ‎‡9 1‏
919 ‎‡a lowexpressionofcd39onregulatorytcellsasabiomarkerforresistancetomethotrexatetherapyinrheumatoidarthritis‏ ‎‡A Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis‏ ‎‡9 1‏
919 ‎‡a lipopolysaccharideinducesinflammatoryhyperalgesiatriggeringatlr4myd88dependentcytokinecascadeinthemicepaw‏ ‎‡A Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4/MyD88-dependent cytokine cascade in the mice paw‏ ‎‡9 1‏
919 ‎‡a lapacholacompoundtargetingpyrimidinemetabolismamelioratesexperimentalautoimmunearthritis‏ ‎‡A Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis‏ ‎‡9 1‏
919 ‎‡a interleukin33receptorst2deficiencyimprovestheoutcomeofstaphylococcusaureusinducedsepticarthritis‏ ‎‡A Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis.‏ ‎‡9 1‏
919 ‎‡a interleukin33receptor‏ ‎‡A Interleukin-33 Receptor‏ ‎‡9 1‏
919 ‎‡a interleukin10limitsintenseacuteswimminginducedmusclemechanicalhyperalgesiainmice‏ ‎‡A Interleukin-10 limits intense acute swimming-induced muscle mechanical hyperalgesia in mice.‏ ‎‡9 1‏
919 ‎‡a inhalationoftheprodrugpi3kinhibitorcl27cimproveslungfunctioninasthmaandfibrosis‏ ‎‡A Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis‏ ‎‡9 1‏
919 ‎‡a inflammasomesareactivatedinresponsetosarscov2infectionandareassociatedwithcovid19severityinpatients‏ ‎‡A Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients‏ ‎‡9 1‏
919 ‎‡a 33inducesneutrophilmigrationinrheumatoidarthritisandisatargetofantitnftherapy‏ ‎‡A IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy‏ ‎‡9 1‏
919 ‎‡a 33enhancesmacrophagereleaseofil1βandpromotespainandinflammationingoutyarthritis‏ ‎‡A IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis‏ ‎‡9 1‏
919 ‎‡a 27counteractsneuropathicpaindevelopmentthroughinductionofil10‏ ‎‡A IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10‏ ‎‡9 1‏
919 ‎‡a 1αpromotesliverinflammationandnecrosisduringbloodstageplasmodiumchabaudimalaria‏ ‎‡A IL-1α promotes liver inflammation and necrosis during blood-stage Plasmodium chabaudi malaria‏ ‎‡9 1‏
919 ‎‡a hydrogensulfideaugmentsneutrophilmigrationthroughenhancementofadhesionmoleculeexpressionandpreventionofcxcr2internalizationroleofatpsensitivepotassiumchannels‏ ‎‡A Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: role of ATP-sensitive potassium channels‏ ‎‡9 1‏
919 ‎‡a targetingnitricoxideasakeymodulatorofsepsisarthritisandpain‏ ‎‡A Targeting nitric oxide as a key modulator of sepsis, arthritis and pain‏ ‎‡9 1‏
919 ‎‡a tgfβsignallingdefectislinkedtolowcd39expressiononregulatorytcellsandmethotrexateresistanceinrheumatoidarthritis‏ ‎‡A TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis.‏ ‎‡9 1‏
919 ‎‡a tgfβ1signalingsustainsarylhydrocarbonreceptor‏ ‎‡A TGFβ1 signaling sustains aryl hydrocarbon receptor‏ ‎‡9 1‏
919 ‎‡a tgfβ1signalingsustainsarylhydrocarbonreceptorahrexpressionandrestrainsthepathogenicpotentialoft17cellsbyanahrindependentmechanism‏ ‎‡A TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of T17 cells by an AHR-independent mechanism‏ ‎‡9 1‏
919 ‎‡a atypicalchemokinereceptorackr2isprotectiveagainstsepsis‏ ‎‡A The Atypical Chemokine Receptor ACKR2 is Protective Against Sepsis.‏ ‎‡9 1‏
919 ‎‡a citrusflavanonenaringeninreducesgoutinducedjointpainandinflammationinmicebyinhibitingtheactivationofnfκbandmacrophagereleaseofil1β‏ ‎‡A The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β‏ ‎‡9 1‏
919 ‎‡a citrusflavononenaringeninreduceslipopolysaccharideinducedinflammatorypainandleukocyterecruitmentbyinhibitingnfκbactivation‏ ‎‡A The citrus flavonone naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κB activation.‏ ‎‡9 1‏
919 ‎‡a nitroxyldonorangelissaltreduceschronicconstrictioninjuryinducedneuropathicpain‏ ‎‡A The nitroxyl donor, Angeli's salt, reduces chronic constriction injury-induced neuropathic pain‏ ‎‡9 1‏
919 ‎‡a nod2signalinginperipheralmacrophagescontributestoneuropathicpaindevelopment‏ ‎‡A The NOD2 signaling in peripheral macrophages contributes to neuropathic pain development‏ ‎‡9 1‏
919 ‎‡a tolllikereceptor9activationinneutrophilsimpairschemotaxisandreducessepsisoutcome‏ ‎‡A Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome.‏ ‎‡9 1‏
919 ‎‡a vinpocetinereduceslipopolysaccharideinducedinflammatorypainandneutrophilrecruitmentinmicebytargetingoxidativestresscytokinesandnfκb‏ ‎‡A Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB.‏ ‎‡9 1‏
919 ‎‡a α1acidglycoproteindecreasesneutrophilmigrationandincreasessusceptibilitytosepsisindiabeticmice‏ ‎‡A α1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice‏ ‎‡9 1‏
919 ‎‡a hesperidinmethylchalconesuppressesexperimentalgoutarthritisinmicebyinhibitingnfκbactivation‏ ‎‡A Hesperidin Methylchalcone Suppresses Experimental Gout Arthritis in Mice by Inhibiting NF-κB Activation‏ ‎‡9 1‏
919 ‎‡a fructose16bisphosphateahighenergyintermediateofglycolysisattenuatesexperimentalarthritisbyactivatingantiinflammatoryadenosinergicpathway‏ ‎‡A Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway‏ ‎‡9 1‏
919 ‎‡a frontlinesciencebloodcirculatingleukocytesfailtoinfiltratethespinalcordparenchymaaftersparednerveinjury‏ ‎‡A Frontline Science: Blood-circulating leukocytes fail to infiltrate the spinal cord parenchyma after spared nerve injury‏ ‎‡9 1‏
919 ‎‡a dmhcbdacannabidiolanalogwithreducedcytotoxicityinhibitstnfproductionbytargetingnfkbactivitydependentona2areceptor‏ ‎‡A DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor‏ ‎‡9 1‏
919 ‎‡a diosminreduceschronicconstrictioninjuryinducedneuropathicpaininmice‏ ‎‡A Diosmin reduces chronic constriction injury-induced neuropathic pain in mice.‏ ‎‡9 1‏
919 ‎‡a differentialregulationofoxidativestressandcytokineproductionbyendothelinetaandetbreceptorsinsuperoxideanioninducedinflammationandpaininmice‏ ‎‡A Differential regulation of oxidative stress and cytokine production by endothelin ETA and ETB receptors in superoxide anion-induced inflammation and pain in mice‏ ‎‡9 1‏
919 ‎‡a df2755aanovelnoncompetitiveallostericinhibitorofcxcr12reducesinflammatoryandpostoperativepain‏ ‎‡A DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain‏ ‎‡9 1‏
919 ‎‡a curcumininhibitssuperoxideanioninducedpainlikebehaviorandleukocyterecruitmentbyincreasingnrf2expressionandreducingnfκbactivation‏ ‎‡A Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-κB activation‏ ‎‡9 1‏
919 ‎‡a contributionofspinalcordglialcellsto50amazonensisexperimentalinfectioninducedpaininbalb100mice‏ ‎‡A Contribution of spinal cord glial cells to L. amazonensis experimental infection-induced pain in BALB/c mice‏ ‎‡9 1‏
919 ‎‡a cinnamoyloxymammeisinisolatedfromgeopropolisattenuatesinflammatoryprocessbyinhibitingcytokineproductioninvolvementofmapkap1andnfκb‏ ‎‡A Cinnamoyloxy-mammeisin Isolated from Geopropolis Attenuates Inflammatory Process by Inhibiting Cytokine Production: Involvement of MAPK, AP-1, and NF-κB.‏ ‎‡9 1‏
919 ‎‡a chalconeattenuatespainandinflammationinexperimentalacutegoutarthritisinmice‏ ‎‡A -Chalcone Attenuates Pain and Inflammation in Experimental Acute Gout Arthritis in Mice‏ ‎‡9 1‏
919 ‎‡a ccr5positiveinflammatorymonocytesarecrucialforcontrolofsepsis‏ ‎‡A CCR5-Positive Inflammatory Monocytes are Crucial for Control of Sepsis‏ ‎‡9 1‏
919 ‎‡a ccr4dependentreductioninthenumberandsuppressorfunctionofcd4foxp3cellsaugmentsifnγmediatedpulmonaryinflammationandaggravatestuberculosispathogenesis‏ ‎‡A CCR4-dependent reduction in the number and suppressor function of CD4Foxp3 cells augments IFN-γ-mediated pulmonary inflammation and aggravates tuberculosis pathogenesis‏ ‎‡9 1‏
919 ‎‡a ccr2expressioninneutrophilsplaysacriticalroleintheirmigrationintothejointsinrheumatoidarthritis‏ ‎‡A CCR2 Expression in Neutrophils Plays a Critical Role in Their Migration Into the Joints in Rheumatoid Arthritis.‏ ‎‡9 1‏
919 ‎‡a ccr2deficientmiceareprotectedtosepsisbythedisruptionoftheinflammatorymonocytesemigrationfromthebonemarrow‏ ‎‡A CCR2-deficient mice are protected to sepsis by the disruption of the inflammatory monocytes emigration from the bone marrow‏ ‎‡9 1‏
919 ‎‡a canonicalpi3kγsignalinginmyeloidcellsrestrictstrypanosomacruziinfectionanddampenschagasicmyocarditis‏ ‎‡A Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.‏ ‎‡9 1‏
919 ‎‡a budleinaasesquiterpenelactonefromalleviatespainandinflammationinamodelofacutegoutarthritisinmice‏ ‎‡A Budlein A, a Sesquiterpene Lactone From, Alleviates Pain and Inflammation in a Model of Acute Gout Arthritis in Mice‏ ‎‡9 1‏
919 ‎‡a bosentanamixedendothelinreceptorantagonistinhibitssuperoxideanioninducedpainandinflammationinmice‏ ‎‡A Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.‏ ‎‡9 1‏
919 ‎‡a apocyninandnox2regulatenfκbbymodifyingthioredoxin1redoxstate‏ ‎‡A Apocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state.‏ ‎‡9 1‏
919 ‎‡a 9thepi3kγaktsignalingpathwaymediatesperipheralantinociceptiveactionofdipyrone‏ ‎‡A 9The PI3Kγ/AKT signaling pathway mediates peripheral antinociceptive action of dipyrone‏ ‎‡9 1‏
919 ‎‡a 5lipoxygenasedeficiencyreducesacetaminopheninducedhepatotoxicityandlethality‏ ‎‡A 5-lipoxygenase deficiency reduces acetaminophen-induced hepatotoxicity and lethality‏ ‎‡9 1‏
919 ‎‡a 15dpgjloadednanocapsulesameliorateexperimentalgoutarthritisbyreducingpainandinflammationinappargammasensitivemannerinmice‏ ‎‡A 15d-PGJ-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice‏ ‎‡9 1‏
919 ‎‡a sarscov2triggeredneutrophilextracellulartrapsnetsmediatecovid19pathology‏ ‎‡A SARS-CoV-2 triggered neutrophil extracellular traps (NETs) mediate COVID-19 pathology‏ ‎‡9 1‏
919 ‎‡a spinalcordoligodendrocytederivedalarminil33mediatesneuropathicpain‏ ‎‡A Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain‏ ‎‡9 1‏
996 ‎‡2 DNB|1017246017‏
996 ‎‡2 BLBNB|000612707‏
996 ‎‡2 ISNI|0000000053864196‏
996 ‎‡2 BLBNB|000177544‏
996 ‎‡2 BLBNB|000614425‏
996 ‎‡2 ISNI|0000000067785122‏
996 ‎‡2 SUDOC|177956763‏
996 ‎‡2 LC|n 2015210347‏
996 ‎‡2 LC|n 2017250307‏
996 ‎‡2 DNB|1255228474‏
996 ‎‡2 ISNI|0000000032560046‏
996 ‎‡2 LC|nr2002043096‏
996 ‎‡2 LC|n 80154907‏
996 ‎‡2 DNB|1217719466‏
996 ‎‡2 ISNI|0000000031122132‏
996 ‎‡2 LC|n 2022250968‏
996 ‎‡2 LC|no2021048652‏
996 ‎‡2 LC|n 2024006164‏
996 ‎‡2 BLBNB|000355969‏
996 ‎‡2 LC|no2011121380‏
996 ‎‡2 ISNI|000000004173006X‏
996 ‎‡2 BLBNB|000165984‏
996 ‎‡2 SUDOC|188336362‏
996 ‎‡2 DNB|141482826‏
996 ‎‡2 ISNI|0000000029433783‏
996 ‎‡2 LC|no 99007503‏
996 ‎‡2 ISNI|0000000084246366‏
996 ‎‡2 PTBNP|242006‏
996 ‎‡2 LC|n 2023253536‏
996 ‎‡2 SUDOC|077158288‏
996 ‎‡2 BLBNB|000317362‏
996 ‎‡2 LC|no2017121192‏
996 ‎‡2 BLBNB|000987708‏
996 ‎‡2 BLBNB|001590126‏
996 ‎‡2 CAOONL|ncf10077732‏
996 ‎‡2 ISNI|0000000076938936‏
996 ‎‡2 BLBNB|000282423‏
996 ‎‡2 SUDOC|073012750‏
996 ‎‡2 BLBNB|000247285‏
996 ‎‡2 BLBNB|000511516‏
996 ‎‡2 ISNI|0000000066509230‏
996 ‎‡2 BLBNB|001194296‏
996 ‎‡2 LC|n 2019044355‏
996 ‎‡2 SUDOC|248685236‏
996 ‎‡2 BLBNB|001479361‏
996 ‎‡2 DNB|1056227249‏
996 ‎‡2 LC|n 2010202898‏
996 ‎‡2 LC|no 98049693‏
996 ‎‡2 DNB|1123306516‏
996 ‎‡2 BLBNB|000400284‏
996 ‎‡2 BLBNB|000599979‏
996 ‎‡2 NTA|238466310‏
996 ‎‡2 SUDOC|23086225X‏
996 ‎‡2 LC|n 2015211042‏
996 ‎‡2 LC|n 82096108‏
996 ‎‡2 BLBNB|000558807‏
996 ‎‡2 ISNI|0000000059542382‏
996 ‎‡2 LIH|LNB:C_q__r__u_;=C_l_‏
996 ‎‡2 BLBNB|000543062‏
996 ‎‡2 BLBNB|000447471‏
996 ‎‡2 LC|n 95122299‏
996 ‎‡2 ISNI|0000000020767832‏
996 ‎‡2 DNB|101453416X‏
996 ‎‡2 DNB|1220039756‏
996 ‎‡2 DNB|124944078‏
996 ‎‡2 LC|n 79013055‏
996 ‎‡2 LC|n 82252142‏
996 ‎‡2 BLBNB|000360259‏
996 ‎‡2 DNB|171357612‏
996 ‎‡2 BLBNB|000222949‏
996 ‎‡2 DNB|140996524‏
996 ‎‡2 DNB|1053082304‏
996 ‎‡2 BLBNB|000264334‏
996 ‎‡2 SUDOC|138784574‏
996 ‎‡2 BLBNB|000541801‏
996 ‎‡2 LC|nb2007013731‏
996 ‎‡2 LC|n 99901131‏
996 ‎‡2 RERO|A013536100‏
996 ‎‡2 BLBNB|000386798‏
996 ‎‡2 ISNI|0000000356612287‏
996 ‎‡2 LC|no2009004713‏
996 ‎‡2 LC|n 2022251518‏
996 ‎‡2 LC|no 98120767‏
996 ‎‡2 ISNI|0000000024152245‏
996 ‎‡2 BLBNB|000546161‏
996 ‎‡2 BLBNB|001452183‏
996 ‎‡2 LC|no2009146403‏
996 ‎‡2 BNF|17922194‏
996 ‎‡2 J9U|987007518694805171‏
996 ‎‡2 LC|n 2010204154‏
996 ‎‡2 BLBNB|000589206‏
996 ‎‡2 LC|n 2006218889‏
996 ‎‡2 DNB|1057455776‏
996 ‎‡2 SUDOC|090488288‏
996 ‎‡2 LC|no2007043419‏
996 ‎‡2 SUDOC|112946879‏
996 ‎‡2 LC|n 2012212754‏
996 ‎‡2 ISNI|0000000032770609‏
996 ‎‡2 LC|no2010052053‏
996 ‎‡2 BLBNB|000605543‏
996 ‎‡2 BLBNB|000522436‏
996 ‎‡2 ISNI|0000000356140718‏
996 ‎‡2 BLBNB|000356423‏
996 ‎‡2 LC|nb2017024346‏
996 ‎‡2 NII|DA08979708‏
996 ‎‡2 BLBNB|000988733‏
996 ‎‡2 ISNI|000000003564355X‏
996 ‎‡2 ISNI|0000000436122413‏
996 ‎‡2 ISNI|0000000069709211‏
996 ‎‡2 ISNI|0000000014859108‏
996 ‎‡2 BLBNB|000247017‏
996 ‎‡2 ISNI|0000000037047313‏
996 ‎‡2 ISNI|0000000035461318‏
996 ‎‡2 DNB|1057741701‏
996 ‎‡2 DNB|1096257459‏
996 ‎‡2 LC|nr2001007508‏
996 ‎‡2 DNB|1056710675‏
996 ‎‡2 ISNI|0000000417047454‏
996 ‎‡2 BLBNB|000535134‏
996 ‎‡2 ISNI|0000000022883562‏
996 ‎‡2 ISNI|0000000496192042‏
996 ‎‡2 ISNI|0000000023689585‏
996 ‎‡2 BLBNB|000546713‏
996 ‎‡2 LC|n 50047918‏
996 ‎‡2 BLBNB|001483160‏
996 ‎‡2 BLBNB|000616513‏
996 ‎‡2 BLBNB|000336744‏
996 ‎‡2 BLBNB|001019763‏
996 ‎‡2 ISNI|0000000071377818‏
996 ‎‡2 BLBNB|000382605‏
996 ‎‡2 LC|n 2014205851‏
996 ‎‡2 BLBNB|000616605‏
996 ‎‡2 ISNI|0000000495738867‏
996 ‎‡2 BLBNB|000198760‏
996 ‎‡2 BLBNB|000309424‏
996 ‎‡2 PTBNP|1521161‏
996 ‎‡2 LC|no2007072408‏
996 ‎‡2 BLBNB|000436274‏
996 ‎‡2 DNB|1057754544‏
996 ‎‡2 BLBNB|001649753‏
996 ‎‡2 SUDOC|25579990X‏
996 ‎‡2 LC|n 88016336‏
996 ‎‡2 PLWABN|9813140089405606‏
996 ‎‡2 LC|nr 89012179‏
996 ‎‡2 BNF|12865992‏
996 ‎‡2 LC|n 84052356‏
996 ‎‡2 ISNI|0000000033416820‏
996 ‎‡2 ISNI|0000000046332159‏
996 ‎‡2 BLBNB|000169587‏
996 ‎‡2 BLBNB|000248713‏
996 ‎‡2 BLBNB|000344539‏
996 ‎‡2 BLBNB|000344538‏
996 ‎‡2 ISNI|0000000054098681‏
996 ‎‡2 ISNI|0000000045356941‏
996 ‎‡2 DNB|105625923X‏
996 ‎‡2 LC|no 98109211‏
996 ‎‡2 DNB|1074663993‏
996 ‎‡2 BLBNB|000717657‏
996 ‎‡2 BLBNB|000552149‏
996 ‎‡2 JPG|500262091‏
996 ‎‡2 BLBNB|000446554‏
996 ‎‡2 BLBNB|000526189‏
996 ‎‡2 PTBNP|240386‏
996 ‎‡2 BLBNB|001553937‏
996 ‎‡2 LC|n 2022033533‏
996 ‎‡2 LC|n 78064010‏
996 ‎‡2 BLBNB|000574424‏
996 ‎‡2 BNF|17000246‏
996 ‎‡2 BLBNB|000319296‏
996 ‎‡2 PTBNP|172696‏
996 ‎‡2 BLBNB|000998571‏
996 ‎‡2 BLBNB|000630461‏
996 ‎‡2 BLBNB|000468346‏
996 ‎‡2 BLBNB|000201724‏
996 ‎‡2 BLBNB|000630462‏
996 ‎‡2 ISNI|0000000042507652‏
996 ‎‡2 BLBNB|000490203‏
996 ‎‡2 PTBNP|1520489‏
996 ‎‡2 SUDOC|148827594‏
996 ‎‡2 LC|n 2024255053‏
996 ‎‡2 ISNI|0000000044854180‏
996 ‎‡2 LC|n 84221157‏
996 ‎‡2 LC|n 2014206942‏
996 ‎‡2 BLBNB|000242275‏
996 ‎‡2 LC|no 96066456‏
996 ‎‡2 LC|no2004018232‏
996 ‎‡2 BLBNB|000335269‏
996 ‎‡2 LC|n 82065945‏
996 ‎‡2 BLBNB|000450371‏
996 ‎‡2 BNF|14617340‏
996 ‎‡2 BLBNB|000391978‏
996 ‎‡2 ISNI|0000000043312355‏
996 ‎‡2 ISNI|0000000021984302‏
996 ‎‡2 BLBNB|000324596‏
996 ‎‡2 DNB|14365778X‏
996 ‎‡2 LC|no2009008260‏
996 ‎‡2 NII|DA10141698‏
996 ‎‡2 LC|n 83172618‏
996 ‎‡2 ISNI|0000000072972694‏
996 ‎‡2 SUDOC|149272677‏
996 ‎‡2 DNB|1041208286‏
996 ‎‡2 BLBNB|001516305‏
996 ‎‡2 LC|n 85828821‏
996 ‎‡2 ISNI|0000000081958528‏
996 ‎‡2 SUDOC|178446130‏
996 ‎‡2 BLBNB|001448775‏
996 ‎‡2 SUDOC|083997873‏
996 ‎‡2 PTBNP|1759416‏
996 ‎‡2 BLBNB|000208144‏
996 ‎‡2 LC|n 83065911‏
996 ‎‡2 NII|DA17840367‏
996 ‎‡2 ISNI|0000000108586518‏
996 ‎‡2 BLBNB|000300366‏
996 ‎‡2 BLBNB|001033875‏
996 ‎‡2 BLBNB|000224616‏
996 ‎‡2 PTBNP|1918183‏
996 ‎‡2 ISNI|0000000114876984‏
996 ‎‡2 SUDOC|242799973‏
996 ‎‡2 DNB|1235798836‏
996 ‎‡2 NSK|000630203‏
996 ‎‡2 ISNI|0000000051706418‏
996 ‎‡2 ISNI|0000000114617026‏
996 ‎‡2 ISNI|0000000051707576‏
996 ‎‡2 BLBNB|000364726‏
996 ‎‡2 SUDOC|195577930‏
996 ‎‡2 LC|n 98910861‏
996 ‎‡2 LC|n 89149882‏
996 ‎‡2 BLBNB|000496013‏
996 ‎‡2 BLBNB|000272418‏
996 ‎‡2 BLBNB|001503518‏
996 ‎‡2 ISNI|0000000500178404‏
996 ‎‡2 LC|n 86138091‏
996 ‎‡2 LC|n 95922476‏
996 ‎‡2 LC|no2007154033‏
996 ‎‡2 DNB|142597015‏
996 ‎‡2 BLBNB|000539036‏
996 ‎‡2 LC|n 88073120‏
996 ‎‡2 ISNI|0000000052092833‏
996 ‎‡2 BLBNB|000529576‏
996 ‎‡2 LC|n 99901165‏
996 ‎‡2 LC|no 97037907‏
996 ‎‡2 ISNI|0000000039939489‏
996 ‎‡2 SUDOC|276364295‏
996 ‎‡2 NUKAT|n 2022163414‏
996 ‎‡2 LC|no2001056206‏
996 ‎‡2 DNB|1148592903‏
996 ‎‡2 BLBNB|000646433‏
996 ‎‡2 BLBNB|000586914‏
996 ‎‡2 PTBNP|216562‏
996 ‎‡2 DNB|1248678753‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Alves-Filho, Jose C.‏ ‎‡q (José Carlos)‏ ‎‡2 LC|n 2023182630‏ ‎‡3 standard number‏
998 ‎‡a Alves-Filho, Jose C.‏ ‎‡2 PLWABN|9810663053205606‏ ‎‡3 viafid‏ ‎‡3 title: (0.97, 'mechanismsunderlyingthehyperalgesicresponsestriggeredbyjoinactivationoftlr4', 'mechanismsunderlyingthehyperalgesicresponsestriggeredbyjointactivationoftlr4')‏